Tarik Skubal’s open-market debut leaves Dodgers at a crossroads — re-sign an ace or lean on youth?
Tarik Skubal, who was traded to the Dodgers at the deadline and helped them to the NLCS, heads to unrestricted free agency after Los Angeles’ early exit.
By SLAM Intel Desk · 5 min read · Updated Oct 17, 2026, 12:59 AM EDT
Reported · Published
The 1–10 score is editorial significance. Measured changes below require source-linked records; the score does not claim a change in win probability or medical severity.
Lede — An ace on the open market, a franchise with choices
Tarik Skubal — the two-time Cy Young winner who needed a midseason trade to reach the NLCS — is heading to unrestricted free agency after the Dodgers’ Game 4 elimination. The moment is straightforward and stark: Skubal will be the top pitcher available, and Los Angeles must now decide whether to pay up to keep a bona fide ace or pivot toward the younger, cheaper pieces it used to replenish the roster.
That decision matters because the Dodgers acquired Skubal at the deadline for a package of prospects, relied on him in the postseason, and must now weigh medical risk, payroll flexibility and a volatile labor environment as they map their 2027 roster.
Why Skubal changes the offseason equation
Skubal’s résumé — two Cy Youngs, strong playoff numbers and 26 combined starts in 2026 (12–7, 2.72 ERA, 186 strikeouts in 158 2/3 innings) — makes him the most attractive pitching commodity this winter. MLB and CBS reporting both mark him as the market’s headliner.
But those same reports point to complications: Skubal underwent a NanoScope procedure on his left elbow and missed time this season before returning. He also just won a record arbitration salary, which establishes a high short-term benchmark. Together, those facts push teams to balance upside against the real risk of paying a long-term, elite guarantee to a pitcher with recent surgery.
Dodgers’ realistic paths — three clean options
1) Re-sign Skubal to a big, multiyear deal: The upside is obvious — you keep a frontline starter and preserve a championship window — but MLB’s reporting suggests that would require a major financial commitment that could limit other moves or internal development plans.
2) Let him reach the open market, pursue shorter-term or lower-cost veteran pitching additions and promote prospects: MLB and Yahoo both note Los Angeles has young pieces (like Josue De Paula) coming up. The Dodgers frequently balance veteran spending with internal infusion; choosing youth reduces near-term payroll but increases performance variance.
3) Bridge or hybrid approach: Offer a shorter, high-AAV deal with deferred guarantees or opt-outs tied to health — a common middle ground that reduces long-term risk while retaining Skubal’s services for some portion of a potential championship window. Much will depend on Skubal’s medicals and how much teams are willing to commit under current CBA uncertainty.
What to watch next
Medicals and official reports on Skubal’s NanoScope recovery will shape the first set of offers. If teams view the procedure as a manageable short-term risk, bidding will escalate quickly.
Labor talks / CBA negotiations are an overlay: with uncertainty around the winter, some franchises may be cautious about very long, big guarantees. Expect the first concrete signals — interest, terms floated, or a rapid agreement — within the first weeks of the market opening.
Finally, watch for Dodgers messaging: whether they publicly prioritize re-signing Skubal, commit to internal options, or focus on preserving flexibility for Shohei Ohtani and other core pieces. None of those paths is final yet, but they will define LA’s winter.
SLAM Explains
The complicated part, made simple.
How Skubal’s free agency works — and why medicals, arbitration history and the CBA matter
A top pitching free agent like Skubal doesn't just negotiate salary and years; teams weigh guaranteed money vs. risk, recent surgeries vs. performance track record, and broader financial uncertainty from collective-bargaining developments. Arbitration history establishes a recent salary benchmark, but long-term guarantees for elite arms now commonly exceed arbitration figures by a wide margin.
Why it matters here
Understanding these mechanics explains why a team that briefly acquired Skubal at the deadline might hesitate to match market guarantees: paying a multiyear, multihundred-million-dollar price for a pitcher with recent elbow work changes roster construction, luxury-tax math and the team’s ability to retain other key players.
Sources and attribution
- MLBPublished Oct 16, 2026, 2:40 AM EDT
Reporting attributed to MLB.
- CBS SportsPublished Oct 16, 2026, 12:28 AM EDT
Reporting attributed to CBS Sports.
- Yahoo SportsPublished Oct 16, 2026, 6:40 PM EDT
Reporting attributed to Yahoo Sports.
Continue the story
